Physician profile

Timothy Leung

Plastic Surgery · Danville, CA

NPI 1366510943

$1,162.09

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$528.33

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $290.06 2023-2024
Mentor Worldwide LLC $179.78 2022
Integra Lifesciences Corporation $143.70 2021
Allergan, INC. $133.92 2019
Acera Surgical, INC. $111.11 2024 Restrata Wound Matrix
Musculoskeletal Transplant Foundation INC. $108.64 2024
Acell, INC. $58.82 2019
Davol INC. $43.16 2020
Baxter Healthcare $38.67 2020
Intuitive Surgical, INC. $35.71 2020
Avanos Medical $18.52 2024 On-Q* Pump and Accessories

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Timothy Leung

$1,162.09

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/971777/timothy-leung

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.